The APPLAUSE-IgAN results demonstrate that targeted, disease-modifying therapy can preserve long-term kidney function.

Greater disease activity and higher proteinuria levels were associated with a greater risk for VTE among patients with LN.

Please provide your email address to receive an email when new articles are posted on . At 36 weeks, patients receiving sparsentan experienced a mean 49.8% reduction in proteinuria from baseline.

Please provide your email address to receive an email when new articles are posted on . Including the duration of proteinuria remission may better predict which patients with IgA nephropathy will ...

Retrospective cohort study. Data from all hospitalized pregnant women between 2009 and 2014 with new onset isolated proteinuria of over 300 mg/24 h at admission were obtained. Follow-up was performed ...

Sudden cardiac arrest, while rare, was somewhat more likely for young adults whose lab values indicated proteinuria approximately 10 years prior. The findings were based on a study of 6.8 million ...

Significant proteinuria reduction maintained at one year, regardless of immunosuppressant use or baseline proteinuria levels Complete proteinuria ...

As part of a community screening study to assess the long-term health outcomes among residents of Walkerton, Ontario, after contamination of its municipal water supply by Escherichia coli O157:H7 and ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window LONG BEACH, ...

Elevated levels of HER2, VCAM, and TWEAK indicated proteinuria, study authors say of their new findings. LN is common in people with pediatric-onset systemic lupus erythematosus (SLE), with a reported ...

THE continuing function of transplanted kidneys depends on the development of a degree of "tolerance" between graft and recipient and the judicious use of immunosuppressive therapy to further this ...